NCT03688061 - Class II Invariant Chain HCV Vaccine Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

August 4, 2019

Study Completion Date

August 4, 2022

Conditions

Hepatitis C

Interventions

BIOLOGICAL

ChAd3-hliNSmut

Attenuated chimpanzee adenovirus (ChAd) vectored vaccine against HCV

BIOLOGICAL

MVA-hliNSmut

Modified Vaccinia Ankara (MVA) vectored vaccine against HCV

Trial Locations (2)

Centre for Cinical Vaccinology and Tropical Medicine, Univeristy of Oxford, Oxford

Hepatology Clinical Trial Unit, John Radcliffe Hospital, Oxford